Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Phidea.Inc.

Phidea was founded in Milan in 1982, as a Drug Development Company, and in 1991 the Spanish subsidiary, based in Madrid, started its activities. Since its foundation Phidea has built a broad know how in global product development, starting its involvement after the definition of the chemical entity of the active pharmaceutical ingredient, and bringing it to registration and supporting its commercialisation. Phidea can follow all the development thanks to the strong partnerships created with Companies specialised in each step of drug development, and directly working in clinical development.
Phidea's services start with the identification of patent strategy, followed by the coordination of the activities of the Partners involved both in pharmaceutical formulation definition, stability trials, first experimental batch production, and in design and conduct of the pharmacological/toxicological development plan.
Through the years Phidea specialised in Clinical Development, managing directly in all Europe multinational pre registration clinical trials (phase I-Phase III), post marketing clinical trials (Phase IV), as well as epidemiological and observational studies (mega trials). Thanks to this broad range of activities Phidea may now offer its support in all product life cycle. Today Phidea is the ideal partner of those Companies that for any reason need to outsource the development of a specific drug from patent submission to registration in Europe.


Contact Details:
Madre Carmen del Niño Jesùs, 3
Madrid
28002
Spain
Tel:(34) 91.7452520
Fax:(34) 91.7450653
Email:info.phidea@phidea.com
WWW:

www.phidea.com/




BioNews Results for Phidea.Inc.:

Latest Pfizer reorganization has to affect some former local workers
Business Review:  Nov 15 2009 2:50PM Matching: nc
Woman accused of faking breast cancer for implants
ABC 7:  Nov 15 2009 9:34AM Matching: nc
Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Genetic Engineering News:  Nov 15 2009 8:17AM Matching: nc
Drug firm expanding NC operation, adding 260 jobs
WCNC:  Nov 15 2009 2:58AM Matching: nc
Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Pharma Live:  Nov 14 2009 10:40PM Matching: nc
Promote your company here: BioNewsCast - Press Release Distribution

View more Phidea.Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 294 times since April 2007, the link to the organisation's website has been followed 77 times

Recent Search Terms used to find this page: phidea inc. | phidea | .

Search for more companies in Madrid

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Phidea.Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.